(Q37582994)

21 August 2017

1 reference

title

Alpha 1-adrenoceptor pharmacome: alpha 1L-adrenoceptor and alpha 1A-adrenoceptor in the lower urinary tract (English)

1 reference

21 August 2017

Atsushi Nishimune

1

1 reference

21 August 2017

Fumiko Suzuki

2

1 reference

21 August 2017

Hatsumi Yoshiki

3

1 reference

21 August 2017

Shigeru Morishima

4

1 reference

21 August 2017

Ikunobu Muramatsu

5

1 reference

21 August 2017

publication date

19 August 2009

1 reference

International Journal of Urology

21 August 2017

published in

1 reference

21 August 2017

volume

17

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

31-37

1 reference

Alpha1-adrenoceptor subtypes and lower urinary tract symptoms

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Alpha adrenoceptor antagonists in the year 2000: is there anything new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Molecular biology of alpha-adrenergic receptors: implications for receptor classification and for structure-function relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Alpha1-adrenoceptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Alpha 1-adrenergic receptor regulation: basic science and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Prostatic alpha 1-adrenoceptors and uroselectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Early efficacy of silodosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

alpha1- and alpha2-adrenoceptors in BPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

On the importance of the "antagonist assumption" to how receptors express themselves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

The receptor concept: pharmacology's big idea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Pharmacological characterization of two distinct alpha 1-adrenoceptor subtypes in rabbit thoracic aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Expression of distinct alpha 1-adrenoceptor phenotypes in the iris of pigmented and albino rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Contractile actions of imidazoline alpha-adrenoceptor agonists and effects of noncompetitive alpha1-adrenoceptor antagonists in human vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Native profiles of alpha(1A)-adrenoceptor phenotypes in rabbit prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Cloning of rabbit alpha(1b)-adrenoceptor and pharmacological comparison of alpha(1a)-, alpha(1b)- and alpha(1d)-adrenoceptors in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Quantifying receptor properties: the tissue segment binding method - a powerful tool for the pharmacome analysis of native receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Identification of alpha-1L adrenoceptor in rabbit ear artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1L-adrenoceptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Splice isoforms of alpha(1a)-adrenoceptor in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Evaluation of beta1L-adrenoceptors in rabbit heart by tissue segment binding assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

"Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2009.02368.X

10.1111/J.1442-2042.2009.02368.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference